Clifton is hardly new to the global medical devices firm. In 2012, he joined a medical supply company responsible for Latin America that was bought by Medtronic within two years. As part of the ...

Highlights of the third quarter include: Commercial Endeavors Marie-Claude Jaques, our new Chief Commercial Officer, has now completed her first full quarter of engagement with the company, along with ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...

Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...

New device receives Health Canada approval after LHSC team participates in global study to prove safety and efficacy ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

A list of all devices included in the in vitro study provided by Medtronic, St. Jude, and Boston Scientific and their year of manufacture. St. Jude ICD 1 Atlas DR (V-240) 2001 St. Jude CRT-ICD 1 ...